These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 16781257)

  • 1. Studies on uterine contractility following mifepristone and various routes of misoprostol.
    Gemzell-Danielsson K; Bygdeman M; Aronsson A
    Contraception; 2006 Jul; 74(1):31-5. PubMed ID: 16781257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Review of medical abortion using mifepristone in combination with a prostaglandin analogue.
    Fiala C; Gemzel-Danielsson K
    Contraception; 2006 Jul; 74(1):66-86. PubMed ID: 16781264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomised controlled trial of mifepristone in combination with misoprostol administered sublingually or vaginally for medical abortion up to 13 weeks of gestation.
    Hamoda H; Ashok PW; Flett GM; Templeton A
    BJOG; 2005 Aug; 112(8):1102-8. PubMed ID: 16045525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of mifepristone and sublingual misoprostol for early medical abortion.
    Lin M; Li YT; Chen FM; Wu SF; Tsai CW; Chen TH; Kuo TC
    Taiwan J Obstet Gynecol; 2006 Dec; 45(4):321-4. PubMed ID: 17175490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized trial of mifepristone in combination with misoprostol administered sublingually or vaginally for medical abortion at 13-20 weeks gestation.
    Hamoda H; Ashok PW; Flett GM; Templeton A
    Hum Reprod; 2005 Aug; 20(8):2348-54. PubMed ID: 15878927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simultaneous very low dose mifepristone and vaginal misoprostol for medical abortion.
    Kapp N; Borgatta L; Ellis SC; Stubblefield P
    Contraception; 2006 May; 73(5):525-7. PubMed ID: 16627039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Misoprostol dose and route after mifepristone for early medical abortion: a randomised controlled noninferiority trial.
    von Hertzen H; Huong NT; Piaggio G; Bayalag M; Cabezas E; Fang AH; Gemzell-Danielsson K; Hinh ND; Mittal S; Ng EH; Chaturachinda K; Pinter B; Puscasiu L; Savardekar L; Shenoy S; Khomassuridge A; Tuyet HT; Velasco A; Peregoudov A;
    BJOG; 2010 Sep; 117(10):1186-96. PubMed ID: 20560941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can vaginal misoprostol be administered 1 to 3 days after mifepristone without loss of efficacy or an increase in adverse events?
    Richardson CR
    J Fam Pract; 2001 Jan; 50(1):9. PubMed ID: 11195490
    [No Abstract]   [Full Text] [Related]  

  • 9. Induction of second trimester abortion (12-20 weeks) with mifepristone and misoprostol: a review of 386 consecutive cases.
    Goh SE; Thong KJ
    Contraception; 2006 May; 73(5):516-9. PubMed ID: 16627037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of slow release misoprostol on uterine contractility in early pregnancy.
    Fiala C; Aronsson A; Stephansson O; Gemzell-Danielsson K
    Hum Reprod; 2005 Sep; 20(9):2648-52. PubMed ID: 15919772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomised controlled trial comparing the efficacy of same-day administration of mifepristone and misoprostol for termination of pregnancy with the standard 36 to 48 hour protocol.
    Guest J; Chien PF; Thomson MA; Kosseim ML
    BJOG; 2007 Feb; 114(2):207-15. PubMed ID: 17305893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for shortening the time interval of prostaglandin after mifepristone for medical abortion.
    Schaff E
    Contraception; 2006 Jul; 74(1):42-4. PubMed ID: 16781259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mifepristone plus vaginal misoprostol vs vaginal misoprostol alone for medical abortion in gestation 63 days or less in Nepalese women: a quasi-randomized controlled trial.
    Chawdhary R; Rana A; Pradhan N
    J Obstet Gynaecol Res; 2009 Feb; 35(1):78-85. PubMed ID: 19215552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pharmacokinetics and different regimens of misoprostol in early first-trimester medical abortion.
    Tang OS; Ho PC
    Contraception; 2006 Jul; 74(1):26-30. PubMed ID: 16781256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mifepristone dose in the regimen with misoprostol for medical abortion.
    Marions L
    Contraception; 2006 Jul; 74(1):21-5. PubMed ID: 16781255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increasing women's choices in medical abortion: a study of misoprostol 400 microg swallowed immediately or held sublingually following 200 mg mifepristone.
    Akin A; Dabash R; Dilbaz B; Aktün H; Dursun P; Kiran S; Aksan G; Doğan B; Winikoff B
    Eur J Contracept Reprod Health Care; 2009 Jun; 14(3):169-75. PubMed ID: 19565414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mifepristone vaginally in an early medical abortion regimen: a pilot study.
    Sharma S; El-Refaey H; Mitchel H; Ozturk O; Rodeck C
    Contraception; 2006 Mar; 73(3):261-4. PubMed ID: 16472567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A pilot study of mifepristone and misoprostol administered at the same time for abortion up to 49 days gestation.
    Murthy AS; Creinin MD; Harwood B; Schreiber C
    Contraception; 2005 May; 71(5):333-6. PubMed ID: 15854632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regimens of misoprostol with mifepristone for early medical abortion: a randomised trial.
    Shannon C; Wiebe E; Jacot F; Guilbert E; Dunn S; Sheldon WR; Winikoff B
    BJOG; 2006 Jun; 113(6):621-8. PubMed ID: 16709204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized trial to compare two dosing intervals of misoprostol following mifepristone administration in second trimester medical abortion.
    Chai J; Tang OS; Hong QQ; Chen QF; Cheng LN; Ng E; Ho PC
    Hum Reprod; 2009 Feb; 24(2):320-4. PubMed ID: 19049993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.